The molecular species of 1,2-diacyl-sn-glycerol (DAG), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP), and phosphatidylinositol 4,5-bisphosphate (PIP2) from brains of adult rats (weighing 150 g) were determined. The DAG, isolated from brain lipid extracts by TLC, was benzoylated, and the molecular species of the purified benzoylated derivatives were . The molecular species of PC, PE, PS, and PI were determined by hydrolyzing the lipids with phospholipase C to DAG, which was then benzoylated and subjected to reverse-phase HPLC. PIP and PIP2 were first dephosphorylated to PI with alkaline phosphatase before hydrolysis by phospholipase C. The molecular species composition of phosphoinositides showed predominantly the 18:O-20:4 species (50% in PI and -65% in PIP and PIP2). Diacylglycerol ( 1,2-diacyl-sn-giycero1; DAG) has long been known as an important intermediate for glycerolipid biosynthesis in eukaryotic cells (Kennedy, 1957) . This biosynthetic precursor is formed in endoplasmic reticulum by hydrolysis of phosphatidic acid (PA), and then it is converted t o triglycerides or phosphoglycerides in the same subcellular compartment (Bell and Coleman, 1980 
Diacylglycerol ( 1,2-diacyl-sn-giycero1; DAG) has long been known as an important intermediate for glycerolipid biosynthesis in eukaryotic cells (Kennedy, 1957) . This biosynthetic precursor is formed in endoplasmic reticulum by hydrolysis of phosphatidic acid (PA), and then it is converted t o triglycerides or phosphoglycerides in the same subcellular compartment (Bell and Coleman, 1980) . In recent years DAG has also been shown to be an important effector for a transmembrane signaling system elicited by different sitides were prelabeled by using different radioactive precursors and the radioactive products were analyzed (Nishizuka, 1986 ). An increase in the mass of DAG in different systems after stimulation by different ligands has also been demonstrated (Loeffelholz, 1989; Pelech and Vance, 1988) . However, the source(s) and subcellular site(s) of such receptor-mediated generation of DAG have not been firmly established. Recently phosphatidylcholine (PC) has been postulated to be the source of DAG in several signal-transducing systems (Exton, 1990) .
One way to distinguish such receptor-mediated formation and metabolism of DAG from de novo biosynthetic DAG is to analyze the molecular species of DAG in these systems. The phosphoinositides in most systems have been shown to be comprised mostly (60-80%) of one single molecular species, i.e., l-stearoyl-2-arachidonoyl-sn-glycerol derivative, and therefore the DAG formed from inositides should consist of the same species. In contrast, the biosynthetic DAG or the DAG from sources other than inositides should contain different fatty acids. Therefore, an analysis of the molecular species of DAG may provide some indications regarding its source and possible site of formation. This has been attempted by some workers who used a sensitive radiometric method in which the DAG was converted to 32P-phosphatidate by [32P]ATP in the presence of either endogenous or exogenous DAG kinase and then the 32P-labeled phosphatidates (as dimethyl esters) were separated from each other by either argentation TLC or HPLC (Van Rooijen et al., 1985; Kennerly, 1987) . However, a good separation of different molecular species of phosphatidate was not achieved by these methods.
The present work was undertaken to develop a sensitive method for the quantitative analysis of molecular species of DAG in different biological systems. The methodology was based on the demonstration by several workers that reverse-phase HPLC could be used for good resolution of different molecular species of DAG (generated from hydrolysis of phosphoglycerides by phospholipase C) after acylation to the acetyl (Nakagawa and Horrocks, 1983), benzoyl (Blank et al., 1984) , or other derivatives (Batley et al., 1980; Krueger et al., 1984) . We have adapted these methods, especially that described for the reverse-phase HPLC separation of benzoyl DAG, and used an internal standard to quantify different molecular species of DAG present in rat brain.
DAG has been shown to be present in small quantities in brain, and it has been shown that there is a rapid postmortem increase in its amount in brain (Banschbach and Geison, 1974; Aveldano and Bazan, 1975; Ikeda et al., 1986) . A preponderance of 18:O and 20:4 fatty acids in this DAG indicated that the rapid postmortem increase in its level was probably due to the hydrolysis of brain phosphoinositides. We have verified this directly by quantifying the postmortem changes in the molecular species of rat brain DAG and also have analyzed the molecular species of different phosphoglycerides, including the inositides. These results are presented here.
MATERIALS AND METHODS

Materials
Sprague-Dawley rats (5 weeks old, weighing 150-160 g) were obtained from Harlan Laboratories (Indianapolis, IN, U.S.A.). Benzoic anhydride, 4-pyrrolidinopyridine (CPP), I ,2-distearoyl-sn-glycerol, phospholipase C (Baciflus cereus), and calf intestine alkaline phosphatase were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). PUFA-2, a GLC standard mixture of polyunsaturated fatty acids, was obtained from Supelco (Bellefonte, PA, U.S.A.). All the solvents for HPLC were HPLC grade, and other solvents were chemical grade. TLC plates (silica gel 60) were purchased from Merck (Cherry Hill, NJ, U.S.A.). Dry benzene was prepared by distilling it from calcium hydride. I-Stearoyl-2- [5,6,8,9,11,12,14, 15-3H] arachidonoyl-sn-glycerophosphoryl choline was purchased from NEN-Dupont (Boston, MA).
Extraction and purification of DAG
Rats were anesthetized with diethyl ether, and their forebrains (cerebrum and cerebellum) were quickly excised and homogenized in chloroform/methanol ( I : 1, I2 ml/g of tissue) with a Polytron (Brinkmann) homogenizer. A known amount (-30 nmol/g of brain) of internal standard, i.e., 1 ,f-distearoyl-sn-glycerol, was added to the homogenate. The homogenate was centrifuged at low speed (1,000 g, 10 min), and the supernatant was saved. The residue was dispersed in water (0.5 ml/g of tissue) by agitation in a sonic bath, and this dispersion was rehomogenized in chloroform/methanol ( 1 : 1, 6 ml/g of original tissue). This second homogenate was centrifuged (1,000 g, LO min), the supernatant was combined with the first supernatant, and the residue was saved for acidic extraction (see below). To the combined supernatants, an additional amount of chloroform was added (9 ml/g of tissue) and mixed well, and 0.9% aqueous NaCl(5.5 ml/g of tissue) was added to the extract to separate the phases (Folch et al., 1957) . The mixture was vortex-mixed and centrifuged (1,000 g, 5 min), and the upper layer was removed. The lower layer was dried in a rotary evaporator, and the residue was dissolved in chloroform (3.5 ml/g of tissue) and, when necessary, stored at -20°C under nitrogen. This lipid extract by a neutral solvent mixture was spotted on a 20-X 20-cm TLC plate (Merck silica gel 60, 0.25 mm thick) as a band (lipid extract from -I0 mg of tissue/cm), and the plate was developed with toluene/ether/methanol (80: 10: 10 by volume) up to 10 cm from the origin. The DAG band (Rf = 0.60) was identified by comparison with the standard DAG chromatographed side-by-side after spraying with Primuline (0.00 1%) (Wright, 197 I ) and viewing under UV light. The band was scraped off, and the DAG was extracted three times from TLC powder with 2 ml of diethyl ether by sonication for 30 s followed by centrifugation (1,000 g, 5 min). The ether was removed by blowing NZ, and the DAG was used immediately for benzoylation.
Purification of other lipids
Phospholipids [PC, phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylinositol (PI)] present in the neutral extract were separated from each other by TLC using two developments in the solvent system of chloroform/methanol/0.25% KCl/ethyl acetateln-propanol (30: 9:6:18:25 by volume) (Hedegaard and Jensen, 1981) . The bands were visualized by spraying with Primuline and identified by comparison with authentic standards (chromatographed side-by-side). The bands were scraped off, and the lipids were extracted from the powders with either chloroform/methanol (2: 1 vol/vol) for PC, PS, and PE or chloroform/methanol (2:l vol/vol) containing 0.25% HCI for PI. The HCI was removed by adding 0.25 volume of water to the extract to separate the phases, the upper layer was removed, and the lower layer was dried by blowing N2. Polyphosphoinositides were isolated from the tissue residues, left after neutral chloroform/methanol extraction, by extracting with chloroform/methanol/12 M HCI (200: 100: 0.75 by volume, 16 ml/g of brain) and centrifuged, and the supernatant was transferred to another tube. To the supernatant 0.25 volume of 1 M HCl was added, mixed well, and centrifuged. The upper layer was removed, and the lower phase was washed once with Folch upper phase (Folch et al., 1957) and then evaporated to dryness by blowing Nz. The residue was dissolved in 2 ml of chloroform/methanol/water (75:25:2 by volume), and the extract was spotted as a band on a TLC plate impregnated with 1.2% potassium oxalate (Hajra et al., 1988) . The plate was developed with chloroform/ methanol/7.4 M NH40H/water (40:48:5: 10 by volume) followed by n-propanol/7.4 M NH,OH/water (65:20: 15 by volume) (Grove et al., 198 1) . Bands were localized after spraying with Primuline, and the bands containing PI 4-phosphate (PIP) and PI 4,5-bisphosphate (PIP2) were extracted from the TLC scrapings by dispersing them three times with 10 ml of chloroform/methanol/ 12 MHCl(66.6:33.3:0.25 by volume). To the combined extracts 0.25 volume of water was added, mixed well, and centrifuged, and the upper layer was removed. The lower layer was filtered through a PTFE filter (pore size, 0.45 pm) to remove insoluble material, and the solvents were removed under Nz. The dried PIP and PIP2 residues were subjected to enzymatic dephosphorylation to convert them to PI as described below.
Hydrolysis with alkaline phosphatase
PIP and PIPz are not hydrolyzed by bacterial phospholipase C, and, therefore, these lipids were first dephosphorylated to PI, which could then be converted to DAG. PIP and PIPz were hydrolyzed to PI by alkaline phosphatase by the method of Ehle et al. (1985) . The lipids were dried down under Nz in Reacti-Vials (Pierce Chemical Co.) and then magnetically stirred in a reaction mixture (final volume, 0.5 ml) containing 10 mM Tris-HC1 buffer (pH 7.4), sodium deoxycholate (3 mM), and alkaline phosphatase (2 U) for 6 h at 37°C. The reaction was stopped by adding 5.0 ml of chloroform/methanol(2: 1 vol/vol) followed by 1 ml of 1 A4 HCl. After mixing and centrifuging, the lower layer was transferred to another tube and dried under N2, and the PI formed was purified by TLC as described above.
Phospholipase C hydrolysis
PC, PI, PS, and PE were sonicated with 0.30 ml of 0.25% Triton X-100 in 50 mMTris-HC1 buffer (pH 7.9, and these mixed micelles were then incubated with 10 U of phospholipase C (from B. cereus) at 37°C for 6 h (Sundler et al., 1978) . The reaction was terminated by chloroform/methanol/ 1 M HCI as described above, and the DAG from the lower layer was purified by TLC (toluene/ether/methanol80: 10: 10 by volume). Authentic standard l-~tearoyl-2-[~H]arachidonoyl-sn-glycerol-3-phosphocholine was converted to the corresponding [3H]DAG by using the same procedure.
Benzoylation of DAG
The purified DAG in dry ether was quantitatively transferred to a Reacti-Vial with dry ether, and the solvent was removed by blowing N2. To the dry DAG (-10-40 nmol) 100 p1 of dry benzene and 20 pl of a solution containing 6.8 pmol of 4-PP and 5.5 pmol of benzoic anhydride in dry benzene were added, and the mixture was magnetically stirred under NZ at room temperature for 1 h. The reaction was stopped by adding 0.1 ml of methanol, and the mixture was stirred for another 5 min. The mixture was then spotted on TLC plates as a band and developed with hexane/diethyl ether/7.4 M N h O H (55:45: 1 by volume). The benzoyl DAG band (R, = 0.65) was scraped off, extracted three times with 2 ml of ether, and used for purification by HPLC.
Purification of benzoyl DAG by normal-phase HPLC
The normal-phase HPLC was performed using a Waters M-45 stainless steel solvent delivery system and a silica gel column (25 X 0.46 cm; pore size, 5 pm; Rainin) attached to a Spectroflow Kratos 773 UV monitoring system. The benzoyl DAG sample in ether was filtered through a PTFE filter (pore size, 0.45 pm) to remove particulate matter, and the solvent was removed by blowing NZ. The residue was dissolved in cyclohexane, and a 2 0 4 aliquot was injected into the column. Benzoyl DAG was eluted isocratically using cyclohexane/ether (96.3:3.7 vol/vol) at a flow rate of 1 ml/min at room temperature. The elution was monitored at 228 nm, and the benzoyl DAG peak was collected and dried under Nz.
Separation of molecular species of DAG
The DAG fraction collected from normal-phase HPLC was dried, dissolved in acetonitrile, and injected into an octadecyl silica gel reverse-phase column (25 X 0.46 cm; Rainin). The molecular species were eluted isocratically using acetonitrile/isopropanol (70:30 vol/vol) at a flow rate of 1 ml/min at room temperature. The eluate was monitored at 228 nm, and the peak areas were integrated using a Nelson analytical PC integrator with a 900 series interface attached to the monitoring system.
Identification of reverse-phase HPLC peaks by GLC
For the purpose of identification, each peak collected from the HPLC column was dried and methanolyzed by heating for 15 min at 60°C with 0.5 ml of 13% BF3 in methanol. Two milliliters of hexane and I .5 ml of water were added to the mixture, mixed well, and centrifuged. The upper hexane layer was transferred to another tube, and the lower layer was extracted two more times with 2 ml of hexane. The combined hexane layers after washing with water were dried under Nz, dissolved in a small volume of dichloromethane, and injected into the gas chromatographic column.
The gas chromatography was performed using a HewlettPackard gas chromatograph (model 5800) equipped with a fused silica capillary column (30 m X 0.2 mm) coated with SP 2330 (cyanopropyl silicone from Supelco) and a flame ionization detector. The camer gas was helium, and the area under each peak was determined using a Hewlett-Packard integrator (model 3396A). The peaks were identified by comparing the retention values with those of known standards.
Postmortem changes in the molecular species of DAG
To analyze the changes of molecular species and amounts of DAG, the rats were lightly anesthetized with ether. For the zero-time points, the skull was opened, and the brain was excised with a spatula and immediately (< 10 s) dropped into liquid Nz. For the time course study, the rats were decapitated, and the whole heads were opened, put into plastic bags, and incubated at 37°C (>I min time course) for the indicated interval (0.5, 1.0, 3.0, 12, and 30 min). After incubation, the brains were rapidly excised from the heads and dropped immediately into liquid nitrogen. The frozen brains were homogenized in chlorofo~m/methanol, and the DAG was isolated from the extracts as described above.
RESULTS
Purification of DAG
DAG (Rf = 0.6) migrated just above the wide cholesterol band (Rf = 0.5) and was well separated from other neutral lipids or free fatty acid (Rf = 0.36) in the solvent system used for TLC. Recovery of DAG from brain extract was -80435% (Table 1 ). Alkyl and alkenyl acyl glycerol, if present, were located just above the DAG band.
Conversion of different phospholipids to DAG PC, PS, PI, and PE had R f values of 0.15,0.22,0.28, and 0.50, respectively, in the TLC system used. PIP and PIPz had R f values of 0.21 and 0.33, respectively, in the TLC system used for the oxalated plates. By TLC examination, it was found that the conversion of PIP and PIP2 to PI by alkaline phosphatase was complete. By TLC analysis, it was also found that phospholipase C from B. cereus completely hydrolyzed all phospholipids. The phospholipase C from Clostridium perfringens did not hydrolyze PI but hydrolyzed other lipids.
Benzoylation of DAG and purification of benzoyl DAG
The benzoylation reaction using 4-PP as the catalyst went to completion within 1 h (Fig. 1) . After the reaction, the excess benzoic anhydride was converted to methyl benzoate by addition of methanol, and the benzoyl DAG was purified by TLC. In the TLC system used, the benzoyl DAG had an Rf value of 0.65, well separated from both methyl benzoate (R, = 0.9) and the catalyst (Rf = 0). The recovery of the benzoyl DAG after benzoylation and TLC was -90% (Table 1) .
Benzoyl DAG was further purified by normal-phase HPLC to remove impurities extracted from TLC plates and also to remove small amounts of ether analogs of DAG if they were present. In the HPLC system used, the benzoyl DAG was eluted out as a single peak with a retention time of 13 min. In this system the benzoyl derivative of alkyl acyl glycerol had an R f value of 6.7 min, and that for alkenyl acyl glycerol was 5.6 min. The presence of ether analogs was noted when DAG was derived from phosphoglycerides, especially from PE. Very little, if any, of the ether analogs of DAG was present in the TLC and HPLC systems used for the isolation of free DAG.
Separation and identification of molecular species of DAG
The elution profile of purified brain benzoyl DAG from the reverse-phase HPLC column is shown in Fig.  2 . There are a total of 18 peaks plus the peak for the internal standard, i.e., benzoylated distearoyl glycerol. This chromatogram was typical of the brain DAG profile obtained 1-2 min after decapitation (see below). From the total area under all the peaks and from the amount of the 1,2-distearoyl-sn-glycerol added as the internal standard and the area of that peak (Fig. 2) , it was calculated that the amount of DAG present was 98 nmol/g of brain for that particular experiment (Table 2).
The peaks were identified by collecting each one from the eluate and then analyzing the fatty acids released after methanolysis by gas chromatography. Peaks containing a single molecular species, e.g., peak 10, were easily identified by the 1: 1 molar proportion of two fatty acids seen after gas chromatography. Peaks containing multiple molecular species, e.g., peak 8, were identified by the molar proportions of different fatty acids seen after gas chromatography and also by plotting the relative retention time with the effective 
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To the total brain lipid extract a trace amount of 1-stearoyl-2-[5,6,8,9,11,12,14,1 5-3H]archidonoyl-sn-glycerol was added, and the extract was analyzed for different molecular species of DAG as described in the text. Radioactivity in the aliquots at each stage of purification and in the final HPLC eluate (peak 10 in Fig. 2 ) was determined. These counts, after correction for the counts taken out in the aliquots, are presented here. donoyl-sn-glycerol(2.76 X 1 O5 cpm) was benzoylated with benzoic anhydride using 4-PP as the catalyst in dry benzene (total volume, 450 pl) as described in the text. At the indicated times, 30 pl of the reaction mixture was taken out and spotted on a TLC plate, which was developed in hexane/ether/NH,OH (55:45:1 by volume). The spots corresponding to DAG (R, = 0.60) and benzoyl DAG (R, = 0.65) were scraped out, and the radioactivity in the scrapings was determined. The result was given as the percentage of radioactivity present in the benzoyl DAG fraction. Duplicate experiment showed less than approximately k5O/0 variability at the initial intervals (<20 min).
profiles obtained for PI and PIP2, which were quite different from that for PC, are shown in Figs. 4 and 5, respectively. The peaks are numbered the same way as in Fig. 2 , and their identities are the same as in Table  2 . The relative amount (in mol%) of each peak is given in Table 3 . Table 3 also shows the percent composition of molecular species for PE and PS.
Postmortem changes in the molecular species of DAG
The postmortem increase in the total amount of brain DAG, calculated from the amount of internal standard recovered after HPLC separation, is shown in Fig. 6 . Although the amounts of all DAG species increased, this increase was more pronounced for some species than others. The changes in the major molecular species are shown in Fig. 7 . The postmortem changes of both relative and absolute amount of each peak as analyzed by HPLC are shown in Table 4 . The position assigned for the fatty acids at the sn-1 and sn-2 position of the glycerol moiety is arbitrary, with the assumption that the more saturated one is present at C-1.
DISCUSSION
Derivatives of DAGs
with the amount present for a typical chromatogram are given in Table   0 -20:4 (peak lo), 16:O-16:0 (peak 13), and 16:O-18:l (peak 12; this peak was mixed with other minute components) (Fig. 2 and Table 2 ).
The identities Of each peak 2. The major peaks Seen were 16:0-20:4 (peak 5 ) ? 18:
M-1 cm-l), which was the Same for all the species re-
Molecular species of brain phosphoglycerides
The HPLC elution profile of the DAG (benzoylated) obtained from total brain PC is shown in Fig. 3 . Elution TLC, a different catalyst (4-PP) for benzoylation, and an internal standard ( 1,2-distearoyl-sn-glycerol) for quantification. A different catalyst was used, because FIG. 2. Separation profile of benzoyl DAG by reverse-phase HPLC. DAG isolated from rat brains (1 min postmortem) containing the added internal standard, 1,2distearoyl~n-glycerol(30 nmol/g brain), was benzoylated, purified, and subjected to reverse-phase HPLC as described in the text. A total of -20 nmol of benzoyl DAG was injected into the HPLC column. The detector output (Azz8) versus time is plotted here. The composition of each numbered peak is given in Table 2 Total rat brain DAG, after isolation by TLC, was benzoylated, purified, and subjected to HPLC as described in the text. The peak numbers correspond to the separation profile as presented in Fig. 2 . Each peak from the HPLC column was collected, and its fatty acid composition was determined by GLC analysis as described in the text. When more than one species of DAG was present in the peak (more than two fatty acids), the assignment of species was done from the ratio of each fatty acid and the hydrophobicity of each species as described in the text. In the identified peaks the first number indicates the length of the carbon chain and the second the number of double bonds in the chain. In the assignment of the position of the fatty acid, it was arbitrarily assumed that the more unsaturated fatty acid was positioned at C-2. Tr, trace.
in our tests, 4-PP proved to be more effective than dimethylaminopyridine in terms of complete acylation of DAG in a shorter interval without any migration of the acyl groups. Distearoyl glycerol was used as the internal standard, because this moiety is virtually absent from tissue glycerides, and on HPLC it did not overlap with any other molecular species. The use of a fully saturated internal standard, however, raised the question of properly compensating for the loss of species containing unsaturated fatty acyl moieties during the purification of DAG. However, when tested, the total recovery of a species containing highly unsatu- 5 . HPLC separation profile of molecular species of PIPp in rat brain. Rat brain PIP2 was isolated, dephosphorylated to PI, and hydrolyzed to DAG. which was then benzoylated and used for HPLC separation as described in the text. Ten nanomoles of benzoyl DAG obtained from PIP2 was used for the separation. The numberings correspond to Fig. 2 and Table 2. moieties was minimized by rapid processing and, when feasible, conducting the operations under a N2 atmosphere. The rapid processing also prevented any acyl migration ( 1,2-diacylglycerol to 1,3-diacylglyceroI) before the benzoylation step. If the crude lipid extract or purified DAG was stored for long intervals, especially above pH 7, acyl migration occurred, as seen by the presence of the 1,3-isomers as shoulders to the 1,2-diacyl peaks in the HPLC separation profile. The validity of the internal standard method of quantification has been verified against two other quantitative methods. Similar amounts of DAG were obtained when measurements were made after acetylation of the purified DAG with ['4C]acetic anhydride of known specific activity (D. DeMarais, C . Lee, and A. K. Hajra, unpublished data). Also, with the TLCpurified DAG, similar results were obtained when enzymatic phosphorylation by [y3*P]ATP, as described by Preiss et al. (1986) , was used in two experiments (93 and 96 nmol/g of brain as estimated by the above HPLC method vs. 93 and 91 nmol/g of brain when the enzymatic method was used). ' The molecular species composition of DAG ( Fig. 1 and Table 2) reveals that 18:O-20:4 (peak 10) is the I We found that for the enzymatic estimation, DAG from total brain lipid extract should be first purified before phosphorylating with ATP using DAG kinase (Lipidex). When the measurement was done using total brain lipid extract, the amount of DAG was twoto threefold higher than that determined by the benzoylation or acetylation reactions. These high values were probably due to the presence of PA phosphataw in the commercial DAG k i n a (crude Escherichia coli membranes), which hydrolyzes the large amounts of PA present in the brain lipid extracts to DAG. TLC purification of DAG removed the PA, and reproducible results were obtained using the enzymatic phosphorylation method. For PI, PC, PE, and PS, 7b appeared as a shoulder on peak 7a and was not resolved from the larger peak. Therefore, these values represent combined 7a and 7b. main component, a finding indicating that inositides are the precursor for this species. However, peaks corresponding to other lipids (mainly PC), such as 12 (16:O-18:l) and 13 (16:O-16:0) , are also present. The molecular species composition agrees well with the fatty acid composition of rat or mouse brain DAG reported from different laboratories (Sun, 1970; Aveldano and Bazan, 1975; Ikeda et al., 1986) . From the fatty acid DAG was isolated, benzoylated, and then subjected to HPLC as described in the text. The total amount (average of two experiments, which were within 5% of each other) was calculated from the areas under the peaks and comparable area under the internal standard (1 8:O-18:O) peak. Table  2 ). Therefore, it is not possible to deduce such a complex molecular composition of DAG or other lipids from the total fatty acid composition of the lipids. The HPLC method, which separated different molecular species of benzoyl DAG very well, was used to analyze the molecular species of most brain phosphoglycerides (diacyl species), which was not done before. As shown in Table 3 , qualitatively the same molecular species are present in all phosphoglycerides and DAG. However, their quantitative compositions were quite different from one class of lipid to another. For example, in PS and PE (especially in PS), the species containing 22% (peak 7) was present in large amounts but was practically absent in PC. On the other hand, the dipalmitoyl moiety (peak 13) was present in large amounts in PC but not in PS or PE (Table 3) . As expected, the 18:O-20:4 species was the predominant one in the inositides. However, although the compositions of PIP and PIP2 were very close to one another, indicating a precursor-product relationship, the composition of PI was somewhat different (Table 3 ). PI contained comparatively greater proportions of peaks 12, 13, and 16, which consisted mainly of saturated and monounsaturated fatty acids (Table 2) . This difference in composition of PI from PIP and PIP2 probably reflects the fact that the fatty acid composition of de novo biosynthetic PI is mainly saturated and monounsaturated, which is later tailored to the 18:O-20:4 and similar species (Holub and Kuksis, 1978) . This latter PI pool (in the plasma membrane?) is probably the precursor of PIP and PIP2. Another finding of potential interest At each interval, the first column is the concentration (nmol/g of brain), and the second column is the mol% of the individual molecular species. Peak numbers correspond to those in Fig. 2 . Tr, trace. is that although brain PE and PS compositions are similar ( Table 3) , indicative of a precursor-product relationship, a much larger amount of 225 (peak 7a) and much lesser amount of 20:4 (peak 10) are present in PS than in PE. This may be due to compartmentation of different molecular species of PE and the formation of PS from PE in a particular compartment by the base exchange reaction. The rapid postmortem increase in amount of DAG (Fig. 7) is similar to those reported by other authors (Banschbach and Geison, 1974; Ikeda et al., 1986) . From the fatty acid analysis of the DAG formed, it is generally believed that this rapid increase in the concentration of DAG is entirely due to the breakdown of inositides. However, analysis of the molecular species indicated that not only the inositides but also PC was breaking down to DAG, albeit at a different rate. The species from inositides such as 16:O-20:4 and 18:O-20: 4 rapidly increased in content within 1-3 min after death, whereas those coming from PC, e.g., 16:O-18: 1. also increased in content but at a slower rate. This was clearly seen when the relative rates of increase of different species were considered (Fig. 8) . As seen in Fig.  8 , there is a rapid increase in content of 18:O-20:4 and 16:O-20:4 in the first 2 min followed by a relatively slower rate of increase for these two species, which are typical for inositol-containing lipids. There was a simultaneous rapid postmortem decrease in content of PIP and PIP2 (Dawson and Eichberg, 1965; Ikeda et al., 1986 ; authors' unpublished data), a result indicating a phospholipase C-mediated breakdown of these lipids. A slower but steady and parallel rate of increase in content of 16:O-18: 1 and 16:O-16:O species, which are typical of brain PC (Table 3) , is seen, which indicates that there is also a postmortem breakdown of brain PC to DAG.
The present work was undertaken to establish whether or not the source and nature of DAG formed in a biological system could be determined by analyzing the molecular species of DAG in different biological systems so that the messenger and biosynthetic roles of DAG are delineated. The method presented here is fairly sensitive, so that 3-5 nmol of total DAG (300 pmol of individual components) can be quantitatively measured in tissues or in incubation mixtures. The method is tested by studying the postmortem changes of molecular species of DAG in brain, and, as shown here, specific lipids are found to break down at different rates to form DAG. The results are, of course, not easily interpreted with respect to actual source and compartments where these transformations have taken place, because whole brain constitutes several different cell types and subcellular compartments. Using specific cell types and/or subcellular fractions might yield better results with respect to the precursor-product relationship of DAG and specific lipids and also the metabolic fate of the DAG formed. We have used this method to study the formation of DAG in SK-N-SH neuroblastoma cells after muscarinic stimulation and obtained results showing a rapid formation of DAG from inositides but not from PC in these cells (C. Lee, S. K. Fisher, B. W. Agranoff, and A. K. Hajra, manuscript in preparation). These and other studies are in progress in our laboratory to study the detailed mechanisms of formation and turnover of DAG, which acts both as a precursor of lipids and as an effector of signal transductions in most biological systems.
